H-ras oncogene mutation and human papillomavirus infection in oral carcinomas
- PMID: 7912510
- DOI: 10.1001/archotol.1994.01880310059011
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas
Abstract
Objective: Previous in vitro studies have demonstrated that transfection of an activated ras gene induces malignant transformation in epithelial cell lines infected with the human papillomavirus (HPV). The results of these studies support the hypothesis that HPV may cooperate with an activated ras gene in epithelial tumor carcinogenesis. To test this hypothesis in head and neck cancers, we screened 35 oral carcinomas for the presence of HPV DNA and for a mutated H-ras gene.
Design: The design of the study was screening survey type. Twenty-seven oral squamous cell carcinomas and eight verrucous carcinomas were analyzed for the presence of HPV DNA using the polymerase chain reaction, followed by Southern blot and probe hybridization. The tumors were also screened for point mutations of the H-ras gene using the polymerase chain reaction and restriction fragment length polymorphism analysis.
Results: Six (22%) of the 27 oral squamous cell carcinomas demonstrated point mutation in the H-ras gene. In addition, six tumors (22%) were positive for HPV DNA, with three tumors (11%) demonstrating both HPV DNA and H-ras gene point mutation. While the rate of simultaneous HPV infection and ras gene activation by point mutation was 11% in oral squamous cell carcinomas, 25% of oral verrucous carcinomas contained both HPV DNA and mutation in the H-ras gene.
Conclusions: These results suggest a stronger association between HPV infection and activation of the H-ras gene in oral verrucous carcinomas. These results continue to confirm the multihit hypothesis of tumorigenesis and suggest that in some cases of oral cancer at least two of these events are H-ras gene mutation and HPV infection.
Similar articles
-
[Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].Magy Onkol. 2002;46(1):35-41. Epub 2003 Feb 3. Magy Onkol. 2002. PMID: 12050680 Hungarian.
-
Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV).Oral Oncol. 2003 Jun;39(4):405-14. doi: 10.1016/s1368-8375(02)00164-1. Oral Oncol. 2003. PMID: 12676263
-
Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.Laryngoscope. 1994 Aug;104(8 Pt 1):1008-12. doi: 10.1288/00005537-199408000-00016. Laryngoscope. 1994. PMID: 8052064
-
HPV-11- and HPV-16-associated oral verrucous carcinoma.Dermatology. 1996;192(3):217-21. doi: 10.1159/000246369. Dermatology. 1996. PMID: 8726634 Review.
-
Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jul;82(1):57-68. doi: 10.1016/s1079-2104(96)80378-7. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996. PMID: 8843455 Review.
Cited by
-
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.J Clin Oncol. 2021 Jun 10;39(17):1856-1864. doi: 10.1200/JCO.20.02903. Epub 2021 Mar 22. J Clin Oncol. 2021. PMID: 33750196 Free PMC article. Clinical Trial.
-
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance.Commun Biol. 2021 Mar 19;4(1):374. doi: 10.1038/s42003-021-01898-5. Commun Biol. 2021. PMID: 33742110 Free PMC article.
-
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.Int J Mol Sci. 2017 Jan 26;18(2):262. doi: 10.3390/ijms18020262. Int J Mol Sci. 2017. PMID: 28134774 Free PMC article.
-
Molecular Aspects of Head and Neck Cancer Therapy.Hematol Oncol Clin North Am. 2015 Dec;29(6):971-92. doi: 10.1016/j.hoc.2015.07.003. Epub 2015 Oct 17. Hematol Oncol Clin North Am. 2015. PMID: 26568543 Free PMC article. Review.
-
mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.J Natl Cancer Inst. 2014 Aug 5;106(9):dju215. doi: 10.1093/jnci/dju215. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25099740 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous